The Role Of Membrane-Bound Tubulin In Platelet Functions

1981 ◽  
Author(s):  
Y Ikeda ◽  
M Handa ◽  
Y Yoshii ◽  
M Imai ◽  
K Sugiura ◽  
...  
Keyword(s):  
Plasma Membrane ◽  
Shape Change ◽  
Human Platelets ◽  
Binding Activity ◽  
Serotonin Release ◽  
Platelet Membranes ◽  
Coomassie Blue ◽  
Tubulin Subunit ◽  
Membrane Bound

Evidence has been presented which suggests the existence of tubulin, subunit protein of microtubules, as an integral part of plasma membrane of certain cells. We have investigated whether tubulin is also a constituent of platelet plasma membrane or not, and, if so, what the functional significance is? Platelet membranes isolated by glycerol lysis technique according to the method of Barber and Jamieson retained colchicine-binding activity, 6.2 ± 1.4 n mol colchicine per 100 mg platelet membranes. Colchicine-binding activity of platelet membranes was not decreased after membranes were washed 3 times, indicating that colchicinebinding activity of membranes is not due to contamination of loosely bound cytoplasmic soluble tubulin. On SDS-poly- acrylamide gel electrophoresis, platelet membranes revealed Coomassie blue stained band of molecular weight 55,000, which comigrated with purified cytoplasmic tubulin isolated from human platelets by two successive cycles of temperature -dependent polymerization depolymerization as described previously(Ikeda & Steiner, J. Biol. Chem. 251:6135, 1976). Monospecific antibody against platelet tubulin was prepared in rabbits by injecting soluble tubulin at weekly intervals for 4 weeks. Platelets preincubated with anti-tubulin F(ab’)2 fragment showed reduced platelet aggregation and shape change induced by collagen, but not by ADP or epinephrine. Collagen-induced release of 14C-serotonin was also inhibited by anti-tubulin F(ab’)2 fragment while ADP- or epinephrine-induced serotonin release was not inhibited(collagen 2μg/ml:45.6% of control, ADP 10μM:92.0% of control, epinephrine 4μg/ml: 98.0% of control).Our results suggest that membrane-associated tubulin may play important roles in collagen-platelet interactions.

scholarly journals The role of cytoplasmic free calcium in the responses of quin2-loaded human platelets to vasopressin

1984 ◽  
Vol 221 (3) ◽  
pp. 897-901 ◽  
Author(s):  
T J Hallam ◽  
N T Thompson ◽  
M C Scrutton ◽  
T J Rink
Keyword(s):  
Plasma Membrane ◽  
Time Course ◽  
Shape Change ◽  
Thromboxane A2 ◽  
Human Platelets ◽  
Free Calcium ◽  
Similar Time ◽  
Transient Rise ◽  
Thromboxane Production

Responses to vasopressin were studied in human platelets loaded with the fluorescent Ca2+ indicator, quin2. In the presence of 1 mM external Ca2+, vasopressin caused a transient rise in [Ca2+]i from the basal level near 100nM to about 700 nM; peak [Ca2+]i was reached in a few seconds and the level then declined towards resting over several minutes. In the absence of external Ca2+ there was a much smaller rise of similar time-course, suggesting that vasopressin increases [Ca2+]i mainly by stimulated-influx across the plasma membrane but also by partly releasing internal Ca2+. Inhibition of thromboxane A2 formation somewhat reduced the peak [Ca2+]i in the presence of external Ca2+, but had no effect on the response attributed to release of internal Ca2+. With external Ca2+, vasopressin stimulated shape-change, secretion and aggregation. Secretion and aggregation were decreased by about half following blockage of thromboxane production. The ability of vasopressin to induce shape-change and secretion even at near basal [Ca2+]i suggests that activators other than Ca2+ are involved.

Adrenaline Activates Human Platelets But Does Not Cause Primary Aggregation If Thrombin Generation Is Inhibited By Hirudin

1981 ◽  
Author(s):  
J P Cazenave ◽  
A Sutter ◽  
S Hemmendinger ◽  
M L Wiesel ◽  
F Lanza ◽  
...  
Keyword(s):  
Plasma Membrane ◽  
Adenylate Cyclase ◽  
Thrombin Generation ◽  
Shape Change ◽  
Specific Inhibitor ◽  
Human Platelets

Adrenaline(ADR) affects human platelets(PLAT) by binding to a receptors,inhibiting adenylate cyclase and translocating Ca2+ across the plasma membrane. In citrated PLAT-rich plasma(CIT-PRP), ADR induces primary aggregation(1stAGG), which may be followed by 2ndAGG due to the activation of the arachidonate(AA) pathway and the release(REL) of ADP. ADR acts synergistically with other aggregating agents. In contrast, ADR does not aggregate suspensions of washed human PLAT(SWHP) and hirudin(HIR)-PRP. To determine the role of traces of thrombin(THR) on AGG and REL of 14C-5HT of prelabeled PLAT induced by ADR,we have used SWHP and PRP anticoagulated with CIT(13mM), HIR(30 U./ml) or both and examined the effects of addition of HIR(30 U./ml),a specific inhibitor of THR. ADR(1-10μM) does not cause AGG or REL of SWHP,even in the presence of added HIR or CIT. However, ADR(1-10μM) potentiates the effects of ADP and AA on AGG and REL. This is not inhibited by HIR. THR alone (0.02 U./ml) causes shape change of SWHP,addition of ADR(4.5μM) causes extensive AGG and REL, which are inhibited by HIR.In CIT-PRP, ADR(1-10μM)causes 1st AGG followed by 2ndAGG and REL, addition of HIR to CIT-PRP has no effect on AGG and REL. Aspirin(ASA) and/or CP/CPK inhibit 2ndAGG-induced by ADR in CIT-PRP. Addition of ASA+CP/CPK+HIR does not inhibit ADR-induced 1stAGG in CIT-PRP. After addition of CIT to HIR-PRP, ADR does not AGG PLAT. In contrast, ADP causes 1stAGG without REL in HIR-PRP and addition of CIT to HIR-PRP induces 2ndAGG and REL. However, ADR causes 1stAGG and REL, if PRP was prepared from blood to which HIR has been added at the same time of CIT or later. In conclusion: 1) ADR does not cause 1stAGG in SWHP or HIR-PRP if the PLAT have not been exposed to THR during their isolation; 2) traces of THR change the response of PLAT to ADR independently of the effect of CIT on Ca2+ concentrations; 3) the use of CIT-PRP does not prevent completely THR generation.

Physiological Effects of Nonimmune Platelet Associated Immunoglobulin G

1981 ◽  
Vol 45 (01) ◽  
pp. 027-033 ◽  
Author(s):  
K Sugiura ◽  
M Steiner ◽  
M Baldini
Keyword(s):  
Shape Change ◽  
Fluorescein Isothiocyanate ◽  
Recovery Phase ◽  
Human Platelets ◽  
Serotonin Release ◽  
Platelet Volume ◽  
Igg Antibody ◽  
Heterologous Antiserum ◽  
Igg Binding ◽  
Series Of Experiments

SummaryThe function of nonimmune IgG associated with platelets is unknown. In a series of experiments we have investigated this problem, relating amount of platelet-associated IgG (PAIgG) to platelet volume, serotonin release, adherence of platelets to monocytes and platelet senescence. Most of these studies were performed with human platelets. Platelets freed of preexisting PAIgG by incubation at 22° C were incubated with IgG in a series of concentrations ranging from 0.4 — 27.0 X10-6 M. The IgG preparations used were demonstrably free of aggregated forms of the protein. The amount of PAIgG bound to platelets was determined by the use of fluorescein isothiocyanate-conjugated anti-IgG antibody (F-anti-IgG antibody) which was quantified in a fluorospectrophotometer. Newly bound IgG was assayed similarly by the use of F-IgG. A dose-dependent increase in platelet volume was associated with the binding of nonimmune IgG by platelets. The process which leveled off at an IgG concentration of 1.2 —1.5 X10-5 M was almost fully reversible and was not due to platelet shape change or aggregation. Release of serotonin from IgG-treated platelets was relatively small but to the extent that it occurred was positively related to the IgG concentration to which platelets were exposed. Adherence to autologous monocytes studied quantitatively by the use of formaldehyde-fixed cells was also positively related to the amount of IgG on the platelets. Normal or IgG-defident serum had a potent inhibitory (noncompetitive) action on the binding of F-IgG and F-anti-human IgG antibody to human platelets. Cohorts of platelets prepared in rabbits during the recovery phase of immunological thrombocytopenia induced by injection of heterologous antiserum, showed an age-dependent increase of PAIgG and of IgG binding. These results suggest that PAIgG plays a role in the clearance of senescent platelets.

Thrombin-Induced Surface Changes of Human Platelets in Plasma: Their Relation to Serotonin Release

1979 ◽  
Author(s):  
K. Subbarao ◽  
V.V. Kakkar
Keyword(s):  
Membrane Proteins ◽  
Blood Platelets ◽  
Polyacrylamide Gel Electrophoresis ◽  
Protein Band ◽  
Human Platelets ◽  
Serotonin Release ◽  
Glycoprotein I ◽  
Reversible Aggregation ◽  
Coomassie Blue ◽  
Labeling Pattern

Membrane proteins of both control and thrombin-treated platelets were labeled by NaB3H4, reduction of Schiff bases formed between pyridoxal 5′-phosphate and protein amino groups. Examination of the labeled polypeptides by SDS-polyacrylamide gel electrophoresis and fluorography disclosed a different labeling pattern for thrombin-treated platelets. The distributions of Coomassie blue-stained protein from treated and untreated cells were, by contrast, almost identical. Fluorographs of control platelets showed a single intensely labeled protein band (mol wt 90,000) whereas with cells exposed to thrombin (30-60 milliunits) about 10 protein bands with mol wts ranging from 43,000 to 200,000 were typically present. Among these were: thrombin-sensitive protein (mol wt 188,000), glycoprotein I (mol wt 150,000) and actin (mol wt 43,000). When serotonin release was prevented, either by reversing platelet aggregation with low amounts of ADP (0.1-0.3 μM) or by preincubating with 3',5'-ADP (20 μM), an inhibitor of both ADP- and thrombin-induced platelet function, the labeling patterns on fluorographs were similar to the control. These results indicate that blood platelets can undergo reversible aggregation without major changes in their surface topography, whereas thrombin-induced serotonin release appears related to structural alterations in platelet membrane proteins.

scholarly journals Isolation of InsP4 and InsP6 binding proteins from human platelets: InsP4 promotes Ca2+ efflux from inside-out plasma membrane vesicles containing 104 kDa GAP1IP4BP protein

1996 ◽  
Vol 315 (3) ◽  
pp. 1027-1034 ◽  
Author(s):  
Flavia O'ROURKE ◽  
Eileen MATTHEWS ◽  
Maurice B. FEINSTEIN
Keyword(s):  
Plasma Membrane ◽  
Calcium Oxalate ◽  
Binding Sites ◽  
Amino Acid Content ◽  
Membrane Vesicles ◽  
Human Platelets ◽  
Binding Activity ◽  
Plasma Membrane Vesicles ◽  
Internal Peptide ◽  
Inside Out

A low-density membrane fraction from human platelets contained the plasma membrane marker glycoprotein Ib (GpIb) and selective binding sites for InsP4 and InsP6. It was separated from the bulk of InsP3-receptor-containing membranes, but was heterogeneous, probably also containing surface-connected canalicular system and some lighter elements of the internal dense tubule system. After loading with calcium oxalate and re-centrifugation on Percoll gradients, this mixed fraction was subfractionated into light membranes containing all of the GpIb, high-affinity InsP4 binding sites (KD = 18 nM) and phosphate-stimulated Ca2+ transport activity. InsP4 (EC50 0.6 μM), but not InsP3 or InsP6, released up to 35% of the accumulated Ca2+ from these vesicles, which were shown to be inside-out plasma membrane vesicles by a biotinylation labelling technique and selective removal of right-side-out plasma membrane vesicles with streptavidin–agarose. Most of the InsP4, and all of the InsP6, binding was present in the much denser calcium oxalate-loaded subfractions, which were free of GpIb. InsP6 binding activity was chromatographically purified as a 116 kDa protein (KD for InsP6 = 5.9 nM), with an amino acid content and two internal peptide sequences identical to those of 116 kDa vinculin. A 104 kDa InsP4 binding protein (KD for InsP4 = 12 nM), probably identical to GAP1IP4BP described by Cullen, Hsuan, Truong, Letcher, Jackson, Dawson and Irvine [(1995) Nature (London) 376, 527–530], was also isolated. This InsP4 receptor may mediate Ca2+ influx in platelets that occurs subsequent to receptor-stimulated production of InsP3 and unloading of internal Ca2+ stores.

scholarly journals Levels of Human Erythrocyte Membrane-Bound and Cytosolic Glycohydrolases Are Associated with Oxidative Stress in Erectile Dysfunction Patients

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
L. Massaccesi ◽  
G. V. Melzi d’Eril ◽  
G. M. Colpi ◽  
G. Tettamanti ◽  
G. Goi ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Plasma Membrane ◽  
Erectile Dysfunction ◽  
Plasma Membranes ◽  
Lag Time ◽  
Specific Marker ◽  
Human Erythrocyte Membrane ◽  
Key Enzyme ◽  
Membrane Bound

Oxidative stress (OS) and production of NO, by endothelium nitric oxide synthetase (eNOS), are involved in the pathophysiology of erectile dysfunction (ED). Moreover, OS induces modifications of the physicochemical properties of erythrocyte (RBC) plasma membranes and of the enzyme content of the same membranes. Due to their role in signalling early membrane alterations in OS-related pathologies, several plasma membrane and cytosolic glycohydrolases of human RBC have been proposed as new markers of cellular OS. In RBC, NOS can be activated and deactivated by phosphorylation/glycosylation. In this regulatory mechanism O-β-N-AcetylGlucosaminidase is a key enzyme. Cellular levels of O-GlcNAcylated proteins are related to OS; consequently dysfunctional eNOS O-GlcNAcylation seems to have a crucial role in ED. To elucidate the possible association between RBC glycohydrolases and OS, plasma hydroperoxides and antioxidant total defenses (Lag-time), cytosolic O-β-N-AcetylGlucosaminidase, cytosolic and membrane Hexosaminidase, membraneβ-D-Glucuronidase, andα-D-Glucosidase have been studied in 39 ED patients and 30 controls. In ED subjects hydroperoxides and plasma membrane glycohydrolases activities are significantly increased whereas Lag-time values and cytosolic glycohydrolases activities are significantly decreased. These data confirm the strong OS status in ED patients, the role of the studied glycohydrolases as early OS biomarker and suggest their possible use as specific marker of ED patients, particularly in those undergoing nutritional/pharmacological antioxidant therapy.

Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects

2011 ◽  
Vol 392 (3) ◽  
Author(s):  
Ute Bank ◽  
Anke Heimburg ◽  
Astrid Wohlfarth ◽  
Gudrun Koch ◽  
Karsten Nordhoff ◽  
...  
Keyword(s):  
Plasma Membrane ◽  
Low Molecular Weight ◽  
Immune Functions ◽  
Cellular Functions ◽  
Fluorogenic Substrates ◽  
Cellular Effects ◽  
Viable Cells ◽  
Substrate Conversion ◽  
Membrane Bound

Abstract The discovery of the DP4-related enzymes DP8 and DP9 raised controversial discussion regarding the physiological and pathophysiological function of distinct members of the DP4 family. Particularly with regard to their potential relevance in regulating immune functions, it is of interest to know which role the subcellular distribution of the enzymes play. Synthetic substrates as well as low molecular weight inhibitors are widely used as tools, but little is yet known regarding their features in cell experiments, such as their plasma membrane penetration capacity. The fluorogenic substrates Gly-Pro-AMC or (Ala-Pro)2-R110 predominantly detect plasma membrane-bound activities of viable cells (less than 0.1% of fluorochromes R110 or AMC inside viable cells after 1 h incubation). Additionally, the selective and non-selective DP8/9 inhibitors allo-Ile-isoindoline and Lys[Z(NO2)]-pyrrolidide were found to be incapable of passing the plasma membrane easily. This suggests that previously reported cellular effects are not due to inhibition of the cytosolic enzymes DP8 or DP9. Moreover, our enzymatic studies with viable cells provided evidence that DP8 and/or DP9 are also present on the surface of immune cells under certain circumstances and could gain relevance particularly in the absence of DP4 expression. In summary, in cells which do express DP4 on the surface, this archetypical member of the DP4 family is the most relevant peptidase in the regulation of cellular functions.

scholarly journals Morphogenic Effects of Ezrin Require a Phosphorylation-Induced Transition from Oligomers to Monomers at the Plasma Membrane

2000 ◽  
Vol 150 (1) ◽  
pp. 193-204 ◽  
Author(s):  
Alexis Gautreau ◽  
Daniel Louvard ◽  
Monique Arpin
Keyword(s):  
Plasma Membrane ◽  
Epithelial Cells ◽  
Wild Type ◽  
Erm Proteins ◽  
Threonine Residue ◽  
Phosphorylation Event ◽  
Membrane Bound

ERM (ezrin, radixin, moesin) proteins act as linkers between the plasma membrane and the actin cytoskeleton. An interaction between their NH2- and COOH-terminal domains occurs intramolecularly in closed monomers and intermolecularly in head-to-tail oligomers. In vitro, phosphorylation of a conserved threonine residue (T567 in ezrin) in the COOH-terminal domain of ERM proteins disrupts this interaction. Here, we have analyzed the role of this phosphorylation event in vivo, by deriving stable clones producing wild-type, T567A, and T567D ezrin from LLC-PK1 epithelial cells. We found that T567A ezrin was poorly associated with the cytoskeleton, but was able to form oligomers. In contrast, T567D ezrin was associated with the cytoskeleton, but its distribution was shifted from oligomers to monomers at the membrane. Moreover, production of T567D ezrin induced the formation of lamellipodia, membrane ruffles, and tufts of microvilli. Both T567A and T567D ezrin affected the development of multicellular epithelial structures. Collectively, these results suggest that phosphorylation of ERM proteins on this conserved threonine regulates the transition from membrane-bound oligomers to active monomers, which induce and are part of actin-rich membrane projections.

scholarly journals Platelet release reaction and intracellular cGMP

Blood ◽  
1978 ◽  
Vol 52 (3) ◽  
pp. 524-531 ◽  
Author(s):  
A Weiss ◽  
NL Baenziger ◽  
JP Atkinson
Keyword(s):  
Platelet Rich Plasma ◽  
Human Platelets ◽  
Serotonin Release ◽  
Secretory Process ◽  
Release Reaction ◽  
Intracellular Cgmp ◽  
Exogenous Addition ◽  
Human Thrombin ◽  
Platelet Release

Abstract Enchanced cAMP concentrations inhibit the aggregation and release reaction of isolated human platelets and platelet-rich plasma to all known inducing agents. An opposing role for cGMP in this phenomenon has been proposed by some but not by others, and the function of cGMP in this secretory process is unclear. To further elucidate the role of cGMP in the release reaction, the effect of increased concentrations of this cyclic nucleotide on 14C-serotonin release was evaluated utilizing isolated human platelets and highly purified human thrombin or commercially available bovine thrombin. Several recently described stimulators of guanylate cyclase, including sodium nitroprusside, sodium azide, nitrosoquanidines, and ascorbic acid, were found to markedly augment platelet cGMP levels. Enhanced platelet cGMP concentrations produced by these drugs or by the exogenous addition of cGMP and its analogues neither caused these cells to secrete nor modulated the thrombin-induced serotonin release reaction. The inhibition of serotonin release by increased cAMP concentrations was not counteracted by increased cGMP levels. Platelet cGMP concentrations were unaltered by thrombin. These data indicate that cGMP is not an obligatory signal or a modulator of the thrombin-induced platelet release reaction.

Sign in / Sign up

Export Citation Format

Share Document